logo

For the Inventor, By the Inventor

Cedar Grove, NJ, United States of America

Jay P O'Brien

USPTO Granted Patents = 8

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 45(Granted Patents)


Company Filing History:

goldMedal8 out of 4,945 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1985-1991

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4992432 - 3-phenyl-thiazepinones as calcium regulating agents (1991-02-12),
2. 4959359 - Phenyl-thiazepinones as calcium regulating agents (1990-09-25),
3. 4912102 - Analogs of naphtho[1,2-.beta.] [1,4] thiazepin-4(5H)-one (1990-03-27),
4. 4808580 - Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treatment of (1989-02-28),
5. 4652561 - Naphtho[1,2-b]-1,4-thiazepinones (1987-03-24),
6. 4640930 - Naphtho(1,8-bc)-1,5-thiazocinones (1987-02-03),
7. 4559403 - Substituted isoquinolines (1985-12-17),
8. 4544657 - Substituted isoquinolines (1985-10-01),

Title: The Innovative Contributions of Jay P O'Brien

Introduction

Jay P O'Brien is a notable inventor based in Cedar Grove, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, O'Brien has made strides in developing compounds that serve as calcium channel blockers, which are essential in treating ischemia.

Latest Patents

O'Brien's latest patents include innovative compounds such as 3-phenyl-thiazepinones, which are described by specific chemical formulas. These compounds feature various substituents and are designed to regulate calcium channels effectively. The active compounds are particularly useful in medical applications, providing therapeutic benefits for conditions related to ischemia.

Career Highlights

Throughout his career, O'Brien has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has focused on the development of novel compounds that enhance the treatment options available for patients suffering from cardiovascular issues.

Collaborations

O'Brien has collaborated with esteemed colleagues such as Erno Mohacsi and Hans Bruderer, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jay P O'Brien's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in developing effective treatments for ischemia. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…